Lymphadenectomy in elderly patients with high-intermediate-risk, high-risk or advanced endometrial cancer: Time to move from personalized cancer medicine to personalized patient medicine!

被引：9

作者：

Racin, Adelaide ^{[1
]}

Raimond, Emilie ^{[2
]}

Bendifallah, Sofiane ^{[3
,4
]}

Timoh, Krystel Nyangoh ^{[1
]}

Ouldamer, Lobna ^{[5
]}

Canlorbe, Geoffroy ^{[4
]}

Hudry, Nina ^{[6
]}

Coutant, Charles ^{[6
]}

Graesslin, Olivier ^{[5
]}

Touboul, Cyril ^{[7
]}

Collinet, Pierre ^{[8
]}

Bricou, Alexandre ^{[9
]}

Huchon, Cyrille ^{[7
,10
]}

Koskas, Martin ^{[11
]}

Ballester, Marcos ^{[2
,12
]}

Darai, Emile ^{[2
,12
]}

Leveque, Jean ^{[1
]}

Lavoue, Vincent ^{[1
]}

机构：

[1] Univ Rennes 1, CHU Rennes, Serv Gynecol,CLCC Eugene Marquis, Hop Sud,U1242,Chem Oncogenesis Stress & Signaling, 16 Bd Bulgarie, F-35000 Rennes, France

[2] Inst Alix Champagne Univ Hosp, Dept Obstet & Gynaecol, Reims, France

[3] Univ Paris 06, Tenon Univ Hosp, AP HP, Dept Gynaecol & Obstet,IUC, Paris 6, France

[4] Univ Paris 06, INSERM UMR S 707, Epidemiol Informat Syst Modeling, Paris 6, France

[5] Ctr Hosp Reg Univ Tours, Dept Obstet & Gynaecol, Hop Bretonneau, Tours, France

[6] Ctr Lutte Canc Georges Francois Leclerc, Dijon, France

[7] Ctr Hosp Intercommunal, Dept Obstet & Gynaecol, Creteil, France

[8] Ctr Hosp Reg Univ, Dept Obstet & Gynaecol, Lille, France

[9] Univ Paris 13, Jean Verdier Univ Hosp, AP HP, Dept Gynaecol & Obstet, Paris, France

[10] Ctr Hosp Intercommunal, Dept Gynaecol & Obstet, Poissy, France

[11] Hop Xavier Bichat, AP HP, Dept Gynaecol & Obstet, Paris, France

[12] Univ Paris 06, INSERM UMR S 938, Paris 6, France

来源：

EJSO | 2019年 / 45卷 / 08期

关键词：

High-risk endometrial cancer; Elderly; Surgery; Lymphadenectomy; Cancer-specific survival; SENTINEL-NODE BIOPSY; QUALITY-OF-LIFE; ROBOTIC SURGERY; WOMEN; MANAGEMENT; OLDER; AGE; STAGE; MULTICENTER; OUTCOMES;

D O I：

10.1016/j.ejso.2019.02.015

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Background: Pelvic and paraaortic lymphadenectomy are recommended for women with high-intermediate, high-risk and advanced endometrial cancer (EC). Lymphadenectomy is less frequently performed in elderly patients than in younger patients. We examined the survival of elderly women diagnosed with high-risk EC according to whether lymphadenectomy was performed or not. Methods: We selected women over 70 years with high-intermediate risk, high-risk or advanced EC from a multicenter retrospective cohort of women diagnosed between 2001 and 2013. Multivariate logistic regression models and Cox proportional hazards survival methods for overall survival (OS), disease-free survival (DFS) and cancer-specific survival (CSS) were used for analyses. Results: 71 women had lymphadenectomy and were compared with the 213 who did not. Recurrence was similar in both groups (42% vs 33%, respectively, p = 0.17) but more deaths were reported in the group without lymphadenectomy (38% vs 23%, respectively, p < 0.001). There was no difference in adjuvant treatment in the two groups (17% vs 27%, respectively, p = 0.27). Elderly patients without lymphadenectomy had lower 3-year DFS (56% vs 71%, p = 0.076), CSS (67% vs 85%, p < 0.001) and OS (50% vs 71% p < 0.001). The Cox proportional hazard models showed independently poorer prognosis in women without lymphadenectomy (3.027, 95% CI 1.58-5.81, p < 0.001), histology type 2 (3.46, 95% CI 1.51-7.97, p = 0.003) and lymphovascular space involvement (3.47, 95% CI 1.35-8.98, p = 0.01) on 3-year CSS. Conclusion: No lymphadenectomy in elderly patients with high-risk or advanced EC is independently associated with poorer prognosis. Elderly patients with EC should benefit from lymphadenectomy when indicated. (C) 2019 Elsevier Ltd, BASO similar to The Association for Cancer Surgery, and the European Society of Surgical Oncology. All rights reserved.

引用

页码：1388 / 1395

页数：8

共 50 条

[1] The Inform Personalized Medicine Program for High-Risk Paediatric Cancer Patients
van Tilburg, C. M.
Worst, B. C.
Balasubramanian, G. P.
Fiesel, P.
Pfaff, E.
Freitag, A.
Witt, R.
Taylor, L.
Milde, T.
von Deimling, A.
Eggert, A.
Lichter, P.
Capper, D.
Pfister, S. M.
Jones, D. T. W.
Witt, O.
PEDIATRIC BLOOD & CANCER, 2016, 63 : S8 - S8
[2] The INFORM personalized medicine study for high-risk pediatric cancer patients
Worst, Barbara C.
van Tilburg, Cornelis M.
Balasubramanian, Gnana P.
Fiesel, Petra
Capper, David
Boudalil, Miream
Wolf, Stephan
Schmidt, Sabine
Bewerunge-Hudler, Melanie
Schick, Matthias
Freitag, Angelika
Witt, Ruth
Taylor, Lenka
von Deimling, Andreas
Schlesner, Matthias
Eggert, Angelika
Lichter, Peter
Jones, David T. W.
Witt, Olaf
Pfister, Stefan M.
CANCER RESEARCH, 2015, 75
[3] The INFORM personalized medicine study for high-risk pediatric cancer patients.
Worst, Barbara Christine
Pfaff, Elke
Van Tilburg, Cornelis M.
Balasubramanian, Gnana Prakash
Fiesel, Petra
Pajtler, Kristian W.
Freitag, Angelika
Witt, Ruth
Kulozik, Andreas E.
von Deimling, Andreas
Eggert, Angelika
Dirksen, Uta
Lichter, Peter
Capper, David
Pfister, Stefan M.
Jones, David T. W.
Witt, Olaf
JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
[4] Role of systematic lymphadenectomy in patients with intermediate to high-risk early stage endometrial cancer
Kim, Nae Ry
So, Kyeong A.
Kim, Tae Jin
Lim, Kyungtaek
Lee, Ki Heon
Kim, Mi-Kyung
JOURNAL OF GYNECOLOGIC ONCOLOGY, 2023, 34 (03)
[5] The italian personalized medicine program PREME for high-risk neuroblastoma
Capasso, Mario
Brignole, Chiara
Bensa, Veronica
Lasorsa, Vito Alessandro
Sebastiani, Enrico
Cantalupo, Sueva
Sementa, Angela Rita
Mazzocco, Katia
Cafferata, Barbara
Vellone, Valerio Gaetano
Cilli, Michele
Calarco, Enzo
Giusto, Elena
Ciampi, Eleonora
Perri, Patrizia
Corrias, Maria Valeria
Aveic, Sanja
Fruci, Doriana
Quattrone, Alessandro
Tondo, Annalisa
Luksch, Roberto
Mura, Rossella
Rabusin, Marco
De Leonardis, Francesco
Cellini, Monica
Coccia, Paola
Conte, Massimo
Amoroso, Loredana
Garaventa, Alberto
Ponzoni, Mirco
Pastorino, Fabio
CANCER RESEARCH, 2023, 83 (07)
[6] Systematic pelvic and paraaortic lymphadenectomy in early high-risk or advanced endometrial cancer
Christina Fotopoulou
Ahmed El-Balat
Andreas du Bois
Jalid Sehouli
Philipp Harter
Mustafa Z. Muallem
Robert W. Krätschell
Alexander Traut
Florian Heitz
Archives of Gynecology and Obstetrics, 2015, 292 : 1321 - 1327
[7] Systematic pelvic and paraaortic lymphadenectomy in early high-risk or advanced endometrial cancer
Fotopoulou, Christina
El-Balat, Ahmed
du Bois, Andreas
Sehouli, Jalid
Harter, Philipp
Muallem, Mustafa Z.
Kraetschell, Robert W.
Traut, Alexander
Heitz, Florian
ARCHIVES OF GYNECOLOGY AND OBSTETRICS, 2015, 292 (06) : 1321 - 1327
[8] Improving locoregional outcome in high-intermediate-risk and high-risk stage I endometrial cancer with surgical staging followed by brachytherapy
Abakay, Candan Demiroz
Arslan, Sonay
Kurt, Meral
Cetintas, Sibel
RADIATION ONCOLOGY JOURNAL, 2022, 40 (02): : 103 - 110
[9] Innovative personalized medicine in gastric cancer: time to move forward
Lee, J.
Kim, K. -M.
Kang, W. K.
Ou, S. -H. I.
CLINICAL GENETICS, 2014, 86 (01) : 37 - 43
[10] Obesity, lymphadenectomy and survival outcomes in intermediate to high-risk, early-stage endometrial cancer patients
Linkov, Faina
Edwards, Robert P.
Althouse, Andrew
Rauh-Hain, Jose A.
Del Carmen, Marcela G.
Freese, Kyle E.
Kelley, Joseph L.
Olawaiye, Alexander B.
FUTURE ONCOLOGY, 2015, 11 (04) : 607 - 615

← 1 2 3 4 5 →